ZYDUS LIFESCIENCES
Back to Income Statement
|
ZYDUS LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹4,526 Cr | ₹3,860 Cr | ₹1,960 Cr | ₹4,487 Cr | ₹2,134 Cr |
What is the latest Consolidated Net Profit of ZYDUS LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹4,526 Cr |
| Mar2025 | ₹3,860 Cr |
| Mar2024 | ₹1,960 Cr |
| Mar2023 | ₹4,487 Cr |
| Mar2022 | ₹2,134 Cr |
How is Consolidated Net Profit of ZYDUS LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,526 Cr | 17.26 | |
| Mar2025 | ₹3,860 Cr | 96.88 | |
| Mar2024 | ₹1,960 Cr | -56.31 | |
| Mar2023 | ₹4,487 Cr | 110.32 | |
| Mar2022 | ₹2,134 Cr | - | |
Compare Consolidated Net Profit of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹113,450.7 Cr | 1.7% | 1.8% | 5.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 1.7% |
1.8% |
5.9% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses